3Hamacher S, Matern S, et al. Extracellular matrix-from basicresearch to clinical significance: An overview with special consideration of matrix metalloproteinases[J]. Dtsch Med Wochenschr, 2004, 129(38)..1976-1980.
4Visse R, Nagase H, et al. Matrix metalloproteinases and tissue inhibitors of metalioproteinases: structure, function and biochemistry[J]. Circ Res, 2003, 92(4): 827-839.
5Jeziorska M, Nagase H, et al. Immunolocalization of the matrix metalloproteinases gelatinase B and stromelysin 1 in human endometrium throughout the menstrual cycle[J] .J Reprod Fertil, 1996, 107(1) : 43-51.
6Freitas S, Meduri G, et al. Expression of Metallopro. teinases and Th eir Inhibitors in Blood Vesselsin Human Endometrium[J]. Biol Reprod, 1999, 61 (4): 1070-1082.
7Staun-Ram E, Goldman S, et al. Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion[J]. Reprod Biol Endocrinol, 2004, 2:59.
8Ribeiro LA, Turba ME, et al. Matrix Metalloproteinases -2 and -9 in Swine Luteal Tissue Angiogenesis and Angioregression[J]. Veterinary Research Communications. 2007, 31: 193-196.
二级参考文献37
1Ohashi K, Nemoto T, Nakamura K, et aL Increased expression of matrix metalloproteinase7 and 9 and membrane typel-matrix metalloproteinase in esophageal squamous cell carcinomas. Cancer,2000,88(10):2201-2209.
2Morgan AR,Zhang B,Tapper W,et al. Haplotypic analysis of the MMP9 gene in relation to coronary artery disease. J Mol Med,2003,81(5):321-326.
3Joos L, He JQ,Megan B,et al. The role of matrix metaloproteinase polymorphisrns in the rate of decline in lung function. Hum Mol Genet,2002,11(5):569-576.
4Kerkela E,Ala-Aho R, Jeskanen L,et al. Expression of human macrophage metalloelastase (MMP12) by tumor colls in skin cancer. J Invest Dermatol,2000,114(6):1113-1119.
5Ding Y, Shimada Y, Gorrin-Rivas MJ, et al. Clinicopathological significanco of human macrophage metalloelsstase expression in esophageal squamous cell carcinoma. Oncology,2002,63 (4):378-384.
6Szyllo K,Smolarz B,Romanowicz-Makowska H,et al. The promoter polymorphism of the matrix metalloproteinase3 (MMP3)gene in women with ovarian cancer. Exp Clin Cancer Res, 2002,21 (3):357-361.
7Liu PY,Chen JH,Li YH,et al. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction. Thromb Haemost,2003,90(1):132-139.
8Ghilardi G,Biondi ML, Demonti M,et al. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke,2002,33 (10):2408-2412.
9Satsangi J,Chapman RW,Haldar N,et al. A functional polymorphism of the stromelysin gene (MMP3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology, 2001,121(1):124-130.
10Knox JD,Boreham DR,Walker JA,et al .Mapping of the metalloproteinase gene matrilysin(MMP7)to human chromosome11q21-q22. Cytogen Cell Genet, 1996, 72(2-3):179-182.
